In glioma cells, single modification with TRAIL showed an approximately 2 to 3.5-fold enhancement of virus-mediated RFP expression, whereas the dual-modification-induced increase was more than 10-fold compared with that of the A3 virus. The gene discussed is TNFSF10; the disease is central nervous system cancer.